酸抑制EZH2:一种潜在的表观遗传治疗癌症分子
Kirankumar Nalla1, Biji Chatterjee2, Jagadeesha Poyya3
1Department of Plant Sciences, School of Life Sciences, University of Hyderabad, Central University PO, Gachibowli, Hyderabad Telangana 500046.
Cancer genetics
|September 13, 2025
概括
酸 (EA) 有效抑制EZH2,这是癌症中的关键表观遗传调节剂. 这种天然化合物有望通过减少瘤生长和促进细胞死亡来开发新的乳腺癌疗法.
科学领域:
- 表观遗传学和癌症生物学
- 自然产品化学 自然产品化学
- 药物发现 药物发现 药物发现
背景情况:
- 表观遗传失调,包括异常的DNA甲基化和基因素修饰,驱动癌症的开始和进展.
- 通过EZH2 (Zeste同源增强剂2) 介导的H3K27me3修饰对于改变瘤发生的基因表达至关重要.
- 针对像多抑制复合体 (PRC) 组件这样的表观遗传修饰剂是一种有希望的抗癌策略.
研究的目的:
- 为了研究酸 (EA) 和EZH2.2之间的分子相互作用.
- 通过评估EA对癌细胞增殖,细胞亡和体内瘤生长的影响来评估EA的抗癌潜力.
主要方法:
- 用分子对接,表面等离子体共振和分子动态模拟来研究EA-EZH2相互作用.
- 在体外测试 (甲基化,MTT,EB/AO染色,细胞循环,细胞亡) 评估了EA对癌细胞的影响.
- 在活体老鼠异种移植模型中评估了EA的抗瘤疗效.
主要成果:
- 埃拉基酸 (EA) 强烈结合EZH2的活性部位,由分子对接和SPR研究 (KD=3.28E-06) 证实.
- 在实验室中,EA抑制了EZH2活性,降低了H3K27me3水平,并诱导癌细胞亡和自.
- 口服EA显著降低了老鼠异种移植中的瘤大小,降低了增殖标记Ki67和压制性组织蛋白标记.
结论:
- 基酸 (EA) 作为一种强大的EZH2抑制剂.
- EA具有显著的抗癌作用,包括瘤生长抑制和诱导细胞死亡.
- EA代表了乳腺癌治疗的潜在治疗候选者.
相关概念视频
Epigenetic Regulation
3.7K
Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
X-chromosome...
3.7K
Epigenetic Regulation
33.5K
Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
33.5K
Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K
Mitogens and the Cell Cycle
7.7K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
7.7K
Antiepileptic Drugs: Potassium Channel Activators
635
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
635


